Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Shanghai Sixth People'S Hospital has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 actions are assigned to 2 distinct examiners, but both are located within 1 distinct art unit. This indicates a concentrated technical focus despite the use of different reviewers. KAMM, JUDITH MARIE is the busiest examiner, holding 1 pending office action.
The presence of 2 distinct examiners for 2 pending office actions means there is no examiner overlap. KAMM, JUDITH MARIE is one of two individuals each handling a single action. However, the 1 distinct art unit shows that both pending actions are classified within the same technical area of Biotechnology & Pharmaceuticals.
For a practitioner, this profile suggests that while the technical arguments may be similar across the 2 pending office actions, they must be tailored to 2 different examiners. The 1 distinct art unit provides a narrow technical focus for the portfolio. KAMM, JUDITH MARIE and the other examiner each manage 1 of the 2 active matters, requiring a unified technical strategy across 2 distinct examiners.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAMM, JUDITH MARIE | 1 | 43.5% | +56.6% |
| NGUYEN, CAM N | 1 | 84.8% | +12.3% |
| SZNAIDMAN, MARCOS L | 1 | 37.3% | +16.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18191440 | METHOD FOR TREATING CEREBRAL APOPLEXY AND HYPERBILIRUBINEMIA BY COMPOUND FOR INHIBITING COMBINATION OF BILIRUBIN AND TRPM2 CHANNEL | SZNAIDMAN, MARCOS L | 19d overdue |
| 18218117 | COBALTOSIC OXIDE-LOADED TITANIUM DIOXIDE HETEROJUNCTION NANOZYME AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | NGUYEN, CAM N | 70d |
| 18950187 | THUMBTACK NEEDLE DRESSING FOR HEMOSTASIS AFTER OPERATION | KAMM, JUDITH MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18191440 | METHOD FOR TREATING CEREBRAL APOPLEXY AND HYPERBILIRUBINEMIA BY COMPOUND FOR INHIBITING COMBINATION OF BILIRUBIN AND TRPM2 CHANNEL | SZNAIDMAN, MARCOS L | 19d overdue |
| 18218117 | COBALTOSIC OXIDE-LOADED TITANIUM DIOXIDE HETEROJUNCTION NANOZYME AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | NGUYEN, CAM N | 70d |
| 18950187 | THUMBTACK NEEDLE DRESSING FOR HEMOSTASIS AFTER OPERATION | KAMM, JUDITH MARIE | — |
| Art Unit | Apps |
|---|---|
| 1736 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18950187 | THUMBTACK NEEDLE DRESSING FOR HEMOSTASIS AFTER OPERATION | KAMM, JUDITH MARIE | — | §103§112 | Non-Final OA | — | Pending | Nov 18, 2024 |
| 18218117 | COBALTOSIC OXIDE-LOADED TITANIUM DIOXIDE HETEROJUNCTION NANOZYME AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | NGUYEN, CAM N | 1736 | §102§112 | Final Rejection | 70d | Pending | Jul 05, 2023 |
| 18191440 | METHOD FOR TREATING CEREBRAL APOPLEXY AND HYPERBILIRUBINEMIA BY COMPOUND FOR INHIBITING COMBINATION OF BILIRUBIN AND TRPM2 CHANNEL | SZNAIDMAN, MARCOS L | 1628 | §102§103§112 | Final Rejection | 19d overdue | Pending | Mar 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial